Researchers developed a monoclonal antibody (MA6) targeting a novel B-cell antigen (BLCa). This antibody shows promise for identifying B-cell malignancies and nasopharyngeal carcinoma cells.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: